Home

The MASH Game Show

From Risk Stratification to Patient Identification CME

Sheraton Phoenix Downtown

Sunday, October 26, 2025 | 8:00 PM - 9:30 PM TZ

Supported by an independent educational grant from Madrigal Pharmaceuticals.

overview

Metabolic dysfunction-associated steatohepatitis (MASH) is a growing global health problem. Patients with MASH are often underdiagnosed, and thus they may not be benefiting from newly approved therapies that can alter the disease course. In this engaging, fast paced, gameshow-style symposium, compete against your colleagues as you learn critical information from expert faculty about noninvasive testing for MASH, risk stratification, identification of patients who can benefit from liver-directed therapies, and other important topics. Put on your thinking caps and join us for The MASH Gameshow!

This event is neither sponsored by nor endorsed by ACG.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

Moderator

Mazen Noureddin, MD, MHSc

Professor of Medicine

Department of Medicine

Sherrie and Alan Conover Center for Liver Disease & Transplantation

J.C Walter Jr. Transplant Center

Houston Methodist Hospital

Director, Houston Research Institute

CSO and Board Member Summit Clinical Research

Houston, Texas

Panelist

Nadege Gunn, MD, DABOM, CPI, FAASLD

Adjunct Assistant Professor

Texas A&M College of Medicine

Medical Director & Senior Scientific Officer

Velocity Clinical Research

Waco, Texas

Panelist

Naim Alkhouri, MD, FAASLD

Chief Medical Officer

Director of the Steatotic Liver Program

Chief of Transplant Hepatology

Arizona Liver Health

Phoenix, Arizona

AGENDA

7:30 PM TZ

Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video encouraged*

LOCATION

Sheraton Phoenix Downtown

340 N 3rd St, Phoenix, Arizona, 85004

Room: Phoenix Ballroom A (Level 3)

TARGET AUDIENCE

This educational activity is intended for an audience of hepatologists/gastroenterologists, endocrinologists/diabetologists, nurse practitioners, physician assistants, and nurses in the United States.

GOAL STATEMENT

The goal of this activity is for learners to be better able to implement clinical care pathways of sequential application of noninvasive scores and imaging tests to risk stratify patients with risk factors for metabolic dysfunction-associated steatohepatitis (MASH) so that they can receive evidence-based care, including liver-directed therapy when appropriate.

LEARNING OBJECTIVES

[bold]Upon completion of this activity, participants will:[/bold] [para]Have increased knowledge regarding the[/para] [list][item]Pathophysiology of MASH and relationship to comorbid metabolic conditions [/list] [para]Have greater competence related to[/para] [list][item]Implementing sequential noninvasive tests (NITs) to risk stratify patients with MASH [item]Identifying patients with MASH who are candidates for liver-directed MASH therapies [/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[title]For Physicians[/title] [text]Medscape, LLC designates this live activity for a maximum of 1.5 [bold][italic]AMA PRA Category 1 Credit(s)[/italic][super]TM[/super][/bold]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.[/text]